BioCentury's websites will be down for upgrades starting at 11 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Aug 15, 2011
 |  BC Week In Review  |  Clinical News  |  Clinical Status

LAX-101: SPA received

Amarin received an SPA from FDA for the international REDUCE-IT cardiovascular outcomes trial to evaluate AMR101 in combination with a statin vs. a statin alone in about 8,000 patients with elevated triglyceride levels and either coronary heart...

Read the full 165 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >